TipRanks
Go Ultimate55% OFF

Linde (LIN1N) AI Stock Analysis

MX:LIN1N

Linde

(BMV:LIN1N)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring Contracted RevenueLinde’s on-site model anchors revenue in long-duration contracts with major industrial customers, while dedicated plants and pipelines increase switching costs. This combination supports recurring demand, improves planning visibility, and helps protect the company’s competitive position across economic cycles.
Negative Factors
Weak Free-Cash-Flow ConversionAlthough Linde generates substantial operating cash flow, the gap between net income and free cash flow indicates that more earnings are being absorbed by capital spending or working capital. Persistently lower conversion could constrain reinvestment flexibility and reduce cash available for distributions.

Linde (LIN1N) vs. SPDR S&P 500 ETF (SPY)

-15%-10%-5%0%5%10%15%20%25%MX:LIN1N+21.75%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 237.05B
Dividend Yield
1.13%
Average Volume (3M)
702
Price to Earnings (P/E)
34.0
Beta (1Y)
-0.04
Revenue Growth
-3.01%
EPS Growth
-9.70%
Country
Mexico
Employees
64,649
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Linde Business Overview & Revenue Model

Company Description

Linde plc functions as a global industrial gas and engineering powerhouse, extending its operations throughout North and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company's comprehensive product line features atmospher...

Linde Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:1.76%|Next Earnings Date:Feb 10, 2027
Earnings Call SentimentPositive

The call was positive but cautious. Linde delivered quarterly records, broad-based sales and pricing growth, strong cash flow, a substantial project backlog and continued momentum in electronics and selected industrial markets. However, management highlighted meaningful challenges from Lincare, restructuring, margin pressure, European industrial weakness, uneven China demand, energy-cost recovery lags and a guarded fourth-quarter outlook. The number and significance of the stated operating strengths outweighed the challenges, while management emphasized that further improvement work remains.

Positive Updates

Quarterly Records in Sales, Operating Profit and EPS
Sales reached $9.4 billion, operating profit was $2.8 billion and EPS was $4.59, all quarterly records. Sales increased 9% year over year, operating profit grew 8% and EPS grew 9%, or 8% excluding currency.

Negative Updates

Significant Restructuring Charge and Lincare Underperformance
Linde recorded a $425 million restructuring charge, with roughly half related to severance, particularly in lower-growth regions, and the balance primarily related to portfolio and asset actions, mostly in the U.S. home care business, Lincare. Management said Lincare has weighed on overall results, is being restructured and remains under strategic evaluation.

Company Guidance

For the fourth quarter, Linde is guiding an EPS range of $4.40 to $4.50, or 5% to 7% growth, with no prior year currency impact assumed, a 1% headwind sequentially, and no economic improvement assumed, including Lincare; the full year guide is $17.82 to $17.92, with the full year FX benefit increased from a strong 1% last quarter to a weak 2% this quarter. Sale of gas backlog is expected to remain pretty close to $8 billion, with projects that might lead up to around $1 billion starting up for the rest of this quarter, while sale of plant backlog is just under $3 billion and expected to continue to grow over the course of next year. Severance paybacks tend to be in the 1- to 2-year range, with this charge probably closer to the higher 2-year end, full benefits expected in the second half of next year on a full run rate basis, and full benefits within 3 to 4 quarters of the action itself. Electronics growth is expected to remain in the double-digit rate going forward, supported by about $2 billion of backlog projects under execution over the next 2, 3 years.

Linde Risk Analysis

Linde disclosed 17 risk factors in its most recent earnings report. Linde reported the most risks in the "Macro & Political" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Macro & Political - Risks related to catastrophic events or geopolitical conditions that may disrupt the company’s business

Latest Risks Added

0 New Risks

Linde Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

MX:LIN1N against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ECLECL72Outperform$84.98B40.8920.70%0.96%9.33%5.71%
APDAPD65Neutral$70.46B-1521.30-0.32%2.28%4.51%-103.05%
EMNEMN65Neutral$7.61B11.7310.63%5.05%0.40%-6.58%
LYBLYB65Neutral$22.17B41.6012.54%5.01%-1.80%―
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
CCCC43Neutral$2.04B-6.76-170.31%2.59%-1.38%28.10%

* Basic Materials Sector Average

Performance Comparison

0%50%100%MX:LIN1NAPDEMNECLLYBCCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:LIN1N and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:LIN1NLinde Plc9645.201722.7421.75%
APDAir Products and Chemicals, Inc.316.4383.2735.71%
EMNEastman Chemical Company66.5311.4020.67%
ECLEcolab302.9848.3118.97%
LYBLyondellbasell Industries68.6425.1157.70%
CCChemours Company13.531.129.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.